Clinical study of stand-alone transthoracic echocardiography-guided percutaneous occlusion of patent ductus arteriosus

Anatol J Cardiol. 2018 Jul;20(1):30-34. doi: 10.14744/AnatolJCardiol.2018.90001.

Abstract

Objective: We aimed to investigate the feasibility and safety of stand-alone transthoracic echocardiography-guided percutaneous occlusion of patent ductus arteriosus (PDA) without the use of X-ray equipment.

Methods: From January to December 2015, we performed stand-alone transthoracic echocardiography-guided percutaneous PDA occlusion using an occluder delivered via a delivery sheath introduced via femoral vein access without the use of X-ray equipment in 12 PDA patients.

Results: PDA occlusion was successfully performed in all 12 patients. The procedure duration ranged from 30 to 110 min (50.4±22.8 min), and the size of the implanted occluder ranged from 12 to 20 mm (15.2±2.8 mm). No occluder migration, residual shunt, or thrombotic complications were observed in the perioperative period. There was no clinical death, hemolysis, infection, or embolism during patients' hospitalization and the follow-up period.

Conclusion: Stand-alone transthoracic echocardiography-guided percutaneous PDA occlusion without the use of X-ray equipment is a safe and effective procedure.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Cardiac Catheterization / methods*
  • Child
  • Ductus Arteriosus, Patent / diagnostic imaging
  • Ductus Arteriosus, Patent / surgery*
  • Echocardiography*
  • Female
  • Humans
  • Male
  • Retrospective Studies
  • Septal Occluder Device
  • Treatment Outcome
  • Ultrasonography, Interventional
  • Young Adult